VRSK Form 4: CFO Mann Executes 10b5-1 Sale of 300 Shares

Rhea-AI Filing Summary

Verisk Analytics (VRSK) reporting person Elizabeth Mann, Chief Financial Officer and director, disclosed a sale of 300 shares of Verisk common stock on 09/16/2025 at a price of $254.72 per share. After the transaction Ms. Mann beneficially owned 15,165 shares directly. The filing notes the shares were sold pursuant to a pre-established 10b5-1 trading plan entered into on December 13, 2024, and the Form 4 was signed by an attorney-in-fact on 09/16/2025. The form reports a routine, single non-derivative sale by an executive.

Positive

• None.

Negative

• Insider sale of 300 shares disclosed, reducing direct holdings to 15,165 shares (sale price $254.72)

Insights

Financial Analyst

TL;DR: A small, routine insider sale under a pre-established 10b5-1 plan; not a material change to ownership.

The sale of 300 shares at $254.72 represents a modest disposition relative to the reported post-transaction holding of 15,165 shares. Because the trade was executed under a 10b5-1 plan established on December 13, 2024, it follows a pre-authorized schedule and reduces the likelihood that the sale was based on undisclosed, material information. For investors, this appears to be routine liquidity by an executive rather than a signal of changing firm fundamentals.

Corporate Governance Expert

TL;DR: Compliance looks appropriate—transaction disclosed on Form 4 and tied to a documented 10b5-1 plan.

The filing meets Section 16 reporting requirements: it lists the reporting person, relationship to the issuer, transaction details, and an explanation that the sale was made pursuant to a 10b5-1 plan. The presence of an attorney-in-fact signature is documented. From a governance perspective, documented pre-clearance via a 10b5-1 plan and timely Form 4 reporting align with standard insider trading controls.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Mann Elizabeth

(Last) (First) (Middle)

C/O VERISK ANALYTICS, INC.

545 WASHINGTON BOULEVARD

(Street)

JERSEY CITY NJ 07310

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Verisk Analytics, Inc. [ VRSK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		S		300(1)	D	$254.72	15,165	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were sold pursuant to a 10b5-1 plan that Ms. Mann entered into on December 13, 2024.

	/s/ Kathy Card Beckles, Attorney-in-fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Elizabeth Mann (VRSK) disclose on Form 4?

She disclosed a sale of 300 shares of Verisk common stock on 09/16/2025 at $254.72 per share.

How many Verisk shares does Elizabeth Mann own after the sale?

The filing reports she beneficially owned 15,165 shares following the reported transaction.

Was the sale part of a 10b5-1 plan for VRSK insider trades?

Yes. The filing states the shares were sold pursuant to a 10b5-1 plan entered on December 13, 2024.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Kathy Card Beckles, Attorney-in-fact on 09/16/2025.

Does the Form 4 show any derivative transactions for Elizabeth Mann?

No. Table II (derivative securities) contains no reported transactions; only a non-derivative sale is reported.